Literature DB >> 19040590

The insulin gradient phenomenon: a manifestation of the effects of body weight on blood pressure and insulin resistance.

Dagnovar Aristizabal1, Jaime Gallo, Ricardo Fernández, Maria A Restrepo, Nora Zapata, Monica Correa.   

Abstract

The relationship between hyperinsulinemia and hypertension is frequently observed in overweight patients; however, population studies have not confirmed an independent association. A population study was conducted to assess whether differences in body mass index and levels of insulinemia modify cardiovascular hemodynamics and arterial pressure. In all, 322 healthy adults underwent a medical evaluation including insulin sensitivity and cardiac performance assessment with echocardiography. A direct relationship between body mass index and blood pressure (r=0.36; P<.01) was shown along with increments in fasting insulin levels. The underlying and progressive rise in insulin levels during blood pressure increase is named the insulin gradient. Left ventricular systolic indexes were significantly greater in the higher-insulin quartile. These findings suggest that body weight increases accompany a rise in systolic pressure and a drop in insulin sensitivity related to the insulin gradient. Increments in ejection fraction and cardiac output with normal total peripheral resistance are related to the blood pressure shift in these persons.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19040590     DOI: 10.1111/j.1559-4572.2008.00018.x

Source DB:  PubMed          Journal:  J Cardiometab Syndr        ISSN: 1559-4564


  3 in total

1.  Relationship between adiponectin and left atrium size in uncomplicated obese patients: adiponectin, a link between fat and heart.

Authors:  Juan Ybarra; Eugenia Resmini; Francesc Planas; Francesc Navarro-López; Susan Webb; Jose Maria Pou; Alicia Santos; Carlos Ballesta-López
Journal:  Obes Surg       Date:  2009-07-23       Impact factor: 4.129

2.  TRC150094 attenuates progression of nontraditional cardiovascular risk factors associated with obesity and type 2 diabetes in obese ZSF1 rats.

Authors:  Shitalkumar P Zambad; Siralee Munshi; Amita Dubey; Ram Gupta; Rosa Anna Busiello; Antonia Lanni; Fernando Goglia; Ramesh C Gupta; Vijay Chauthaiwale; Chaitanya Dutt
Journal:  Diabetes Metab Syndr Obes       Date:  2011-01-06       Impact factor: 3.168

Review 3.  Vascular effects of rapid-acting insulin analogs in the diabetic patient: a review.

Authors:  Steve Fordan; Philip Raskin
Journal:  Vasc Health Risk Manag       Date:  2009-04-08
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.